Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
« Previous Article | Table of Contents | Next Article »
Circulation Research. 2009;104:15-18
Published online before print November 26, 2008, doi: 10.1161/CIRCRESAHA.108.186429
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
104/1/15    most recent
CIRCRESAHA.108.186429v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Skyschally, A.
Right arrow Articles by Heusch, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Skyschally, A.
Right arrow Articles by Heusch, G.
Related Collections
Right arrow Cell signalling/signal transduction
Right arrow Ischemic biology - basic studies
(Circulation Research. 2009;104:15.)
© 2009 American Heart Association, Inc.

Report

Ischemic Postconditioning in Pigs

No Causal Role for RISK Activation

Andreas Skyschally*, Patrick van Caster*, Kerstin Boengler, Petra Gres, Judith Musiolik, Dustin Schilawa, Rainer Schulz, Gerd Heusch

From the Institut für Pathophysiologie, Universitätsklinikum Essen, Germany.

Correspondence to Prof Dr Gerd Heusch, FRCP, Institut für Pathophysiologie, Universitätsklinikum Essen, Hufelandstrasse 55, 45122 Essen, Germany. E-mail gerd.heusch{at}uk-essen.de

Ischemic postconditioning (IPoC) reduces infarct size following ischemia/reperfusion. Whether or not phosphorylation of RISK (reperfusion injury salvage kinases) (AKT, ERK1/2, P70S6K, GSK3β) is causal for protection by IPoC is controversial. We therefore studied the impact of RISK on IPoC in anesthetized pigs subjected to 90 minutes of left anterior descending coronary artery hypoperfusion and 120 minutes of reperfusion. In protocol 1, IPoC, by 6 cycles of 20/20 seconds of reperfusion/reocclusion (n=13), was compared with immediate full reperfusion (IFR) (n=15). In protocol 2, IPoC (n=4) or IFR (n=4) was performed with pharmacological RISK blockade by IC coinfusion of Wortmannin and U0126. Infarct size was determined by TTC staining, and the expression of phosphorylated RISK proteins by Western blot analysis in biopsies. In protocol 1, infarct size was 20±3% (percentage of area at risk; mean±SEM) with IPoC and 33±4% (P<0.05) with IFR. RISK phosphorylation increased with reperfusion but was not different between IPoC and IFR. In protocol 2, Wortmannin and U0126 blocked the increases in RISK phosphorylation during reperfusion, but infarct size was still smaller with IPoC (15±7%) than with IFR (35±6%; P<0.05).


Key Words: cardioprotection • infarct size • reperfusion injury




This article has been cited by other articles:


Home page
 Exp. Biol. Med.Home page
O. C. Manintveld, M. t. L. Hekkert, N. T. van der Ploeg, P. D. Verdouw, and D. J. Duncker
Interaction Between Pre- and Postconditioning in the In Vivo Rat Heart
Experimental Biology and Medicine, November 1, 2009; 234(11): 1345 - 1354.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
L. Lacerda, S. Somers, L. H. Opie, and S. Lecour
Ischaemic postconditioning protects against reperfusion injury via the SAFE pathway
Cardiovasc Res, November 1, 2009; 84(2): 201 - 208.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
G. Heusch
No RISK, no ... cardioprotection? A critical perspective
Cardiovasc Res, November 1, 2009; 84(2): 173 - 175.
[Full Text] [PDF]

Home page
 Cardiovasc ResHome page
J. Musiolik, P. van Caster, A. Skyschally, K. Boengler, P. Gres, R. Schulz, and G. Heusch
Reduction of infarct size by gentle reperfusion without activation of reperfusion injury salvage kinases in pigs
Cardiovasc Res, August 25, 2009; (2009) cvp271v2.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
K. Boengler, R. Schulz, and G. Heusch
Loss of cardioprotection with ageing
Cardiovasc Res, July 15, 2009; 83(2): 247 - 261.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
P. Sicard, S. Jacquet, K. S. Kobayashi, R. A. Flavell, and M. S. Marber
Pharmacological postconditioning effect of muramyl dipeptide is mediated through RIP2 and TAK1
Cardiovasc Res, July 15, 2009; 83(2): 277 - 284.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
J. Inserte, J. A. Barrabes, V. Hernando, and D. Garcia-Dorado
Orphan targets for reperfusion injury
Cardiovasc Res, July 15, 2009; 83(2): 169 - 178.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
D. Garcia-Dorado, M. Ruiz-Meana, and H. M. Piper
Lethal reperfusion injury in acute myocardial infarction: facts and unresolved issues
Cardiovasc Res, July 15, 2009; 83(2): 165 - 168.
[Full Text] [PDF]

Home page
 Circ. Res.Home page
M. Juhaszova, D. B. Zorov, Y. Yaniv, H. B. Nuss, S. Wang, and S. J. Sollott
Role of Glycogen Synthase Kinase-3{beta} in Cardioprotection
Circ. Res., June 5, 2009; 104(11): 1240 - 1252.
[Abstract] [Full Text] [PDF]

Home page
 Circ. Res.Home page
C. Yin, F. N. Salloum, and R. C. Kukreja
A Novel Role of MicroRNA in Late Preconditioning: Upregulation of Endothelial Nitric Oxide Synthase and Heat Shock Protein 70
Circ. Res., March 13, 2009; 104(5): 572 - 575.
[Abstract] [Full Text] [PDF]


Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search
Copyright © 2009 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited.